Indication
Treatment of opioid-induced constipation in advanced-illness patients who are receiving palliative care when response to usual laxative therapy has not been sufficient.
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- RelistorCanada · 20 MG / ML · Solution · Salix Pharmaceuticals INC · MarketedSame brand
- RelistorCanada · 20 MG / ML · Solution · Salix Pharmaceuticals INC · Authorised · 2 entriesSame brand
- RELISTOR 12 mg/0,6 ml, SOLUCION INYECTABLESpain · 12 mg · polvo y disolvente para solución inyectable · Bausch Health Ireland LimitedSame brand
- RELISTOR 12 mg/0,6 ml, SOLUCION INYECTABLESpain · 12 mg · solución inyectable · Bausch Health Ireland Limited